Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Dec 2, 2009


ShanghaiBio announced the appointment of Michael Lutz as its advisor for ongoing global corporate development activities. Lutz was formerly senior VP of pharmacogenetics partnerships for Clinical Data's PGxHealth division and global general manager of the company's Cogenics division.

Pathway Genomics has appointed Sidney Stolz as its new chief growth officer, responsible for expanding Pathway's direct-to-consumer genetic testing services.

Before coming to Pathway, Stolz was executive VP of Healthcare Solutions. He has also held various executive positions at Towers Perrin and UnitedHealth Group. In 1997, Stolz became the CEO of UHG's global consulting division.

Exagen Diagnostics announced the appointment of Scott Glenn as its new CEO and chairman of its board of directors. Glenn replaces interim CEO Waneta Tuttle.

Prior to joining Exagen, Glenn was managing partner of Windamere Venture Partners and founded several biomedical companies, including Prometheus Laboratories, Santarus, Dexcom, among others. Before joining Windamere Ventures, Glenn was president and CEO of Quidel and held various positions with Allergan Pharmaceuticals.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.